Perioperative use of recombinant human erythropoietin in patients refusing blood transfusions. Pathophysiological considerations based on 5 cases

European Journal of Haematology

Volumn 58, Issue 3, 1997, Pages 154-159

  Wolff, M ^a   Fandrey, J ^a   Hirner, A ^a   Jelkmann, W ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Anaemia; Jehovah's Witnesses; Perioperative red cell production; Recombinant human erythropoietin

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RELIGIOUS GROUP; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030966177     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb00941.x     Document Type: Article

References (28)

1. ADAMSON JW, ESCHBACH JW. Treatment of the anemia of chronic renal failure with recombinant human erythropoietin. Annu Rev Med 1990: 41: 349-360.
2. ADAMSON JW, SPIVAK JL. Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment. Surgery 1994: 115: 7-15.
3. GOODNOUGH LT, RUDNICK S, PRICE TH, et al. Increased-preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989: 321: 1163-1168.
4. MERCURIALI F, GUALTIERI G, SINIGAGLIA L, et al. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Transfusion 1994: 34: 501-506.
5. BIESMA DH, MARX JJM, KRAAIJENHAGEN RJ, FRANKE W, MESSINGER D, VAN DE WIEL A. Lower homologous blood requirements in autologous blood donors after treatment with recombinant human erythropoietin. Lancet 1994: 344: 367-370.
6. BENSON KT. The Jehovah's Witness patient: considerations for the anesthesiologist. Anesth Analg 1989: 69: 647-656.
7. DUDRICK SJ, O'DONNELL JJ, RALEIGH DP, MATHENY RG, UNKEL SP. Rapid restoration of red blood cell mass in severely anemic surgical patients who refuse transfusions. Arch Surg 1985: 120: 721-727.
8. BRIMACOMBE J, SKIPPEN R TALBUTT P. Acute anaemia to a haemoglobin of 14 g/1 with survival. Anaesth Int Care 1991: 19: 581-583.
9. ATABEK U, ALVAREZ R, PELLO MJ, et al. Erythropoietin accelerates hematocrit recovery in post-surgical anemia. Am Surg 1995: 61: 74-77.
10. THOMPSON FL, POWERS JS, GRABER SE. Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease. Am J Med 1990: 90: 398-400.
11. JOHNSON PWM, KING R, SLEVIN ML, WHITE H. The use of erythropoietin in a Jehovah's witness undergoing major surgery and chemotherapy. Br J Cancer 1991: 63: 476.
12. WESTABY S, PARRY AJ, LAMONT R GREBENIK C. Massive descending thoracic aneurysm in a Jehovah's witness: treatment by thromboexclusion. Ann Thorac Surg 1993: 55: 1233-1235.
13. ROTHSTEIN P, ROYE D, VERDISCO L, STERN L. Preoperative use of erythropoietin in an adolescent Jehovah's Witness. Anesthesiology 1990: 73: 568-570.
14. FULLERTON DA, CAMPBELL DN, WHITMAN GJ. Use of human recombinant erythropoietin to correct severe preoperative anemia. Ann Thorac Surg 1991: 51: 825-826.
15. KRAUS P, LIPMAN J. Erythropoietin in patient following multiple trauma. Anesthesia 1992: 47: 962-964.
16. KOESTNER JA, NELSON LD, MORRIS JA, SAFCSAK K. Use of recombinant human erythropoietin in a Jehovah's witness refusing transfusion of blood products. J Trauma 1990: 30: 1406-1408.
17. COLLINS SL, TIMBERLAKE GA. Severe anemia in the Jehovah's witness: case report and discussion. Am J Crit Care 1993: 2: 256-259.
18. MOGHTADER JC, EDLICH RF, MINTZ PD, ZACHMANN GC, HIMEL HN. The use of recombinant human erythropoietin and cultured epithelial autografts in a Jehovah's Witness with a major thermal injury. Burns 1994: 20: 176-177.
19. AKINGBOLA OA, CUSTER JR, BUNCHMAN TE, SEDMAN AB. Management of severe anemia without transfusion in a pediatric Jehovah's witness patient. Crit Care Med 1994: 22: 524-528.
20. TSUJI Y, KAMBAYASHI J, SHIBA E, SAKON M, KAWASAKI T, MORI T. Effect of recombinant human erythropoietin on anaemia after gastrectomy: a pilot study. Eur J Surg 1995: 161: 29-33.
21. VON BORMANN B, WEILER J, AULICH C. Acute treatment with recombinant erythropoietin in patients with pre- and post-operative anemia: a clinical report. Clin Invest 1994: 72: 31-35.
22. CANADIAN ORTHOPEDIC PERIOPERATIVE ERYTHROPOIETIN STUDY GROUP. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993: 341: 1227-1232.
23. SHEINGOLD SH, CHURCHILL DN, MUIRHEAD N, LAUPACIS A. Recombinant human erythropoietin: factors to consider in cost-benefit analysis. Am J Kidney Dis 1991: 17: 86-92.
24. DENTON TA, DIAMOND GA, MATLOFF JM, GRAY RJ. Anemia therapy: individual benefit and social cost. Semin Oncol 1994: 21: 29-35.
25. LEVINE EA, GOULD SA, ROSEN AL, et al. Perioperative recombinant human erythropoietin. Surgery 1989: 106: 432-438.
26. BIESMA DH, VAN DE WIEL A, BEGUIN Y, KRAAIJENHAGEN RJ, MARX JJM. Postoperative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995: 25: 383-389.
27. GREENBURG AG. To transfuse or not to transfuse - that is the question! Crit Care Med 1990: 18: 1045.
28. RUTHERFORD CJ, SCHNEIDER TJ, DEMPSEY H, KIRN DH, BRUGNARA C, GOLDBERG MA. Efficacy of different dosing regiments for human erythropoietin in a simulated perisurgical setting: The importance of iron availability in optimizing response. Am J Med 1994: 96: 139-145.